EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Edwards Lifesciences (EW) Misses Q4 EPS by 4c, Offers Guidance
January 26, 2022 4:17 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.51, $0.04 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2022 EPS of $0.54-$0.62, versus the consensus of $0.60.... More



